Sensei Historical Financial Ratios
| SNSE Stock | USD 0.56 0.03 5.66% |
Sensei Biotherapeutics is promptly reporting on over 83 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 2.44, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 0.0 will help investors to properly organize and evaluate Sensei Biotherapeutics financial condition quickly.
Sensei |
About Sensei Financial Ratios Analysis
Sensei BiotherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Sensei Biotherapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Sensei financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Sensei Biotherapeutics history.
Sensei Biotherapeutics Financial Ratios Chart
Add Fundamental
Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Income Quality
An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.Debt To Equity
A measure of a company's financial leverage calculated by dividing its total liabilities by stockholders' equity, indicating the proportion of equity and debt the company is using to finance its assets.Most ratios from Sensei Biotherapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Sensei Biotherapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sensei Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade Sensei Stock refer to our How to Trade Sensei Stock guide.At present, Sensei Biotherapeutics' Book Value Per Share is projected to increase significantly based on the last few years of reporting. The current year's PB Ratio is expected to grow to 0.31, whereas Operating Cash Flow Per Share is forecasted to decline to (1.20).
Sensei Biotherapeutics fundamentals Correlations
Click cells to compare fundamentals
Sensei Biotherapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sensei Biotherapeutics fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | (8.07) | (10.24) | 1.1 | 0.44 | 0.3 | 0.31 | |
| Book Value Per Share | (2.34) | (1.85) | 5.29 | 3.37 | 2.32 | 2.44 | |
| Free Cash Flow Yield | (0.0156) | (0.0327) | (0.2) | (0.86) | (1.66) | (1.58) | |
| Operating Cash Flow Per Share | (0.29) | (0.58) | (1.09) | (1.27) | (1.15) | (1.2) | |
| Pb Ratio | (8.07) | (10.24) | 1.1 | 0.44 | 0.3 | 0.31 | |
| Free Cash Flow Per Share | (0.29) | (0.62) | (1.17) | (1.28) | (1.15) | (1.21) | |
| Net Income Per Share | (0.65) | (0.67) | (1.35) | (1.59) | (1.22) | (1.28) | |
| Payables Turnover | 0.0212 | 0.0538 | 0.28 | 0.4 | 0.34 | 0.35 | |
| Cash Per Share | 0.008559 | 0.54 | 5.33 | 3.49 | 2.35 | 1.69 | |
| Pocfratio | (64.67) | (32.65) | (5.31) | (1.17) | (0.6) | (0.63) | |
| Interest Coverage | (5.51) | (11.52) | (55.94) | (229.17) | (257.39) | (244.52) | |
| Capex To Operating Cash Flow | (0.006184) | (0.0681) | (0.067) | (0.008225) | (0.005621) | (0.005902) | |
| Pfcf Ratio | (64.27) | (30.57) | (4.98) | (1.16) | (0.6) | (0.63) | |
| Income Quality | 0.51 | 0.88 | 0.82 | 0.8 | 0.94 | 0.63 | |
| Roe | 0.28 | 0.37 | (0.26) | (0.47) | (0.53) | (0.5) | |
| Ev To Operating Cash Flow | (66.51) | (31.75) | (5.15) | (0.92) | (0.39) | (0.41) | |
| Pe Ratio | (29.18) | (28.02) | (4.29) | (0.94) | (0.57) | (0.6) | |
| Return On Tangible Assets | (15.61) | (0.96) | (0.24) | (0.41) | (0.46) | (0.48) | |
| Ev To Free Cash Flow | (66.1) | (29.72) | (4.83) | (0.91) | (0.39) | (0.41) | |
| Earnings Yield | (0.0343) | (0.0357) | (0.23) | (1.07) | (1.76) | (1.67) | |
| Current Ratio | 0.0231 | 4.16 | 30.38 | 11.98 | 11.92 | 7.86 | |
| Tangible Book Value Per Share | (2.34) | (1.85) | 5.29 | 3.37 | 2.32 | 2.44 | |
| Graham Number | 5.84 | 5.29 | 12.68 | 10.98 | 7.98 | 7.58 | |
| Shareholders Equity Per Share | (2.34) | (1.85) | 5.29 | 3.37 | 2.32 | 2.44 | |
| Debt To Equity | (0.23) | (0.01) | 0.004641 | 0.0206 | 0.0376 | 0.0395 | |
| Capex Per Share | 0.001807 | 0.0394 | 0.0731 | 0.0105 | 0.00644 | 0.006118 | |
| Graham Net Net | (2.37) | (2.0) | 5.09 | 3.0 | 2.01 | 2.11 | |
| Interest Debt Per Share | 0.62 | 0.0738 | 0.0487 | 0.0765 | 0.0924 | 0.0878 | |
| Debt To Assets | 13.19 | 0.0265 | 0.004438 | 0.018 | 0.0328 | 0.0312 | |
| Enterprise Value Over E B I T D A | (46.11) | (30.38) | (4.24) | (0.77) | (0.38) | (0.39) | |
| Price Earnings Ratio | (29.18) | (28.02) | (4.29) | (0.94) | (0.57) | (0.6) | |
| Price Book Value Ratio | (8.07) | (10.24) | 1.1 | 0.44 | 0.3 | 0.31 | |
| Price To Operating Cash Flows Ratio | (64.67) | (32.65) | (5.31) | (1.17) | (0.6) | (0.63) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sensei Biotherapeutics is a strong investment it is important to analyze Sensei Biotherapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sensei Biotherapeutics' future performance. For an informed investment choice regarding Sensei Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sensei Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade Sensei Stock refer to our How to Trade Sensei Stock guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sensei Biotherapeutics. If investors know Sensei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sensei Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.19) | Return On Assets (0.27) | Return On Equity (0.45) |
The market value of Sensei Biotherapeutics is measured differently than its book value, which is the value of Sensei that is recorded on the company's balance sheet. Investors also form their own opinion of Sensei Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sensei Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sensei Biotherapeutics' market value can be influenced by many factors that don't directly affect Sensei Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sensei Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sensei Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sensei Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.